U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1987
111
Substance Class Mixture
Created
by admin
on Sat Dec 16 15:15:48 GMT 2023
Edited
by admin
on Sat Dec 16 15:15:48 GMT 2023
Record UNII
1RXS4UE564
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALTEPLASE
INN   MART.   USAN   USP   VANDF   WHO-DD  
INN   USAN  
Official Name English
ALTEPLASE [MART.]
Common Name English
ALTEPLASE [USAN]
Common Name English
ALTEPLASE FOR INJECTION
EP  
Common Name English
alteplase [INN]
Common Name English
ALTEPLASE (GENETICAL RECOMBINATION) [JAN]
Common Name English
ALTEPLASE [VANDF]
Common Name English
TISSUE PLASMINOGEN ACTIVATOR, RECOMBINANT
Common Name English
ALTEPLASE FOR INJECTION [EP MONOGRAPH]
Common Name English
ACTIVASE
Brand Name English
ACTILYSE
Brand Name English
ALTEPLASE [JAN]
Common Name English
ALTEPLASE, RECOMBINANT
Common Name English
ALTEPLASE [PURPLE BOOK CDER]
Common Name English
EC 3.4.21.68
Common Name English
RT-PA
Code English
PLASMINOGEN ACTIVATOR (HUMAN TISSUE-TYPE PROTEIN MOIETY)
Common Name English
TISSUE PLASMINOGEN ACTIVATOR ALTEPLASE
MI  
Common Name English
TPA
Common Name English
ALTEPLASE [USP MONOGRAPH]
Common Name English
Alteplase [WHO-DD]
Common Name English
ALTEPLASE,RECOMBINANT [VANDF]
Common Name English
TISSUE PLASMINOGEN ACTIVATOR ALTEPLASE [MI]
Common Name English
ALTEPLASE (GENETICAL RECOMBINATION)
JAN  
Common Name English
ALTEPLASE,RECOMBINANT
VANDF  
Common Name English
Classification Tree Code System Code
WHO-VATC QB01AD02
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
FDA ORPHAN DRUG 163502
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
FDA ORPHAN DRUG 331410
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
WHO-ATC B01AD02
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
FDA ORPHAN DRUG 431414
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
WHO-ATC S01XA13
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
WHO-VATC QS01XA13
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
NCI_THESAURUS C29750
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
Code System Code Type Description
LACTMED
Alteplase
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
DRUG CENTRAL
5141
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201593
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
DAILYMED
1RXS4UE564
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
EVMPD
SUB32223
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
WIKIPEDIA
Alteplase
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
EVMPD
SUB126952
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
RXCUI
8410
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY RxNorm
DRUG BANK
DB00009
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
EVMPD
SUB05378MIG
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
SMS_ID
100000089921
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
FDA UNII
1RXS4UE564
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
NCI_THESAURUS
C39607
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
USAN
X-35
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
IUPHAR
4985
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
INN
5975
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
MESH
D010959
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
MERCK INDEX
m10894
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY Merck Index
CAS
105857-23-6
Created by admin on Sat Dec 16 15:15:48 GMT 2023 , Edited by admin on Sat Dec 16 15:15:48 GMT 2023
PRIMARY
All of the following components must be present:
ALTEPLASE SINGLE CHAIN
ALTEPLASE TWO CHAIN PROTEIN
Related Record Type Details
PLASMINOGEN
SUBSTRATE->ENZYME
PLASMINOGEN
TARGET->ENZYME
FIBRIN
SUBSTRATE->ENZYME
Related Record Type Details
ALTEPLASE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL
Definition References
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966